Purpose: Audio-Digest Foundation CME/CE activities are designed to provide its learners – physicians and other healthcare professionals – with continuing education that will help identify clinical problems in their practice settings, provide content to help to solve those problems, and increase their application of knowledge to practice.
Audio-Digest Gastroenterology is specifically designed to provide the participant with state-of-the-art information, including, but not limited to, procedures and techniques and/or the diagnosis and management of:
Inflammatory Bowel Disease
Irritable Bowel Syndrome
Gastroesophageal reflux disease
Ulcer disease
Liver disease
Pancreatic disease
Cancer within the digestive system
Endoscopy
Esophageal disease
Colon problems
Transplantation
Nutrition
The goal of this program is to manage and minimize risk factors associated with peptic ulcer disease (PUD). After hearing and assimilating this program, the clinician will be better able to:
1: Assess risk factors and clinical predictors of upper gastrointestinal (GI) bleeding.
2: Describe costs of health care utilization for patients admitted for GI bleeding.
3: Summarize rebleeding occurrences and other outcomes of various proton pump inhibitor therapies.
4: Provide gastroprotection in patients taking antiplatelet agents and nonsteroidal anti-inflammatory drugs.
5: Compare sequential therapy to standard triple therapies for treatment of Helicobacter pylori.
Audio-Digest Gastroenterology is specifically designed to provide the participant with state-of-the-art information, including, but not limited to, procedures and techniques and/or the diagnosis and management of:
Inflammatory Bowel Disease
Irritable Bowel Syndrome
Gastroesophageal reflux disease
Ulcer disease
Liver disease
Pancreatic disease
Cancer within the digestive system
Endoscopy
Esophageal disease
Colon problems
Transplantation
Nutrition
The goal of this program is to manage and minimize risk factors associated with peptic ulcer disease (PUD). After hearing and assimilating this program, the clinician will be better able to:
1: Assess risk factors and clinical predictors of upper gastrointestinal (GI) bleeding.
2: Describe costs of health care utilization for patients admitted for GI bleeding.
3: Summarize rebleeding occurrences and other outcomes of various proton pump inhibitor therapies.
4: Provide gastroprotection in patients taking antiplatelet agents and nonsteroidal anti-inflammatory drugs.
5: Compare sequential therapy to standard triple therapies for treatment of Helicobacter pylori.
